📩 06/01/2021 12:26
As a result of the study initiated by ASELSAN with the Kovid-19 outbreak, the microelectronic optics-based virus diagnosis system, which was developed rapidly and whose patent applications were made, came to the clinical test stage. A domestic and national system was developed with the work of engineers from the ASELSAN Technology and Strategy Management Vice Presidency (TSYGMY), Communication and Information Technologies (HBT) Sector Presidency and Microelectronics Guidance and Electro-Optics (MGEO) Sector Presidency. With this microelectronic optics based system, the Kovid-19 virus is also detected.
ASELSAN has developed an innovative virus diagnosis system that can also be used in the detection of new types of coronavirus (Kovid-19 / SARS-Cov-2). With the emergence of the Kovid-19 outbreak, at the ASELSAN Research Center, chemical and biological
A device development study was initiated to be used in the detection of Kovid-19 with the knowledge obtained within the scope of researches aimed at detecting threats.
Based on antibody-based digital detection, the system detects by optical method using lenses. From patients
The samples taken are incubated on disposable cassettes. Cartridge containing patient sample, artificial
It is analyzed with intelligence software and the result is reported. Virus diagnostic system, intact virus, cartridge
It enables it to be detected optically by holding antibodies that work with key-lock compatibility. ASELSAN made patent applications for the critical components of the system.
With this system, it is aimed to detect viruses that show symptoms of upper respiratory tract infections such as Kovid-19 and influenza simultaneously on a single cassette. During the system tests, studies were carried out with antigens, inactive and active viruses and successful results were obtained.
It is aimed to achieve a 99 percent test accuracy rate for the virus diagnosis system. The system is at the ethical committee approval stage for hospital tests. Turkey Pharmaceuticals and Medical Devices Agency (TİTCK) works with patient samples following the approval will begin shortly. ASELSAN, primarily aims to meet the needs of export followed by Turkey.
Quick solution against the epidemic
ASELSAN has been meeting the needs of the country with domestic and national solutions for the defense industry in many different fields for 45 years. ASELSAN produced fast solutions after the epidemic showed the need for domestic and national solutions in the field of health. ASELSAN; He focused on the virus diagnosis system with his knowledge on the detection of chemical, biological, radiological, nuclear (CBRN) threats. A local and national system was developed with the work of ASELSAN engineers. With this microelectronic optics based system, the Kovid-19 virus is detected.
It will be a fixture of hospitals
Approved tests of the system at Yeditepe University and TUBITAK Biosafety Level 3 (BSL3) Laboratory were completed. Besides, ASELSAN is a member of YÖK KBRN team and works in contact with our universities. Efforts are underway for the device to take its place in hospitals very soon.
Our device is an optical-based system that has been productized in this field for the first time in the world. It can make multiple diagnoses. It is possible to detect more than one disease in one go with the swab sample we take. By changing the disposable cassettes in the device, the application can be designed for the detection of many different kinds of diseases. With the project, it was aimed to develop a device that has a continuity and can turn into a fixture in hospitals for the detection of not only SARS-Cov-2 but all viruses. After the hospital clinical tests are completed, the production process of the device will start and it will take place in hospitals.
Pinpoint disease detection from similar symptoms
By using the infrastructure of universities and laboratories in cooperation with the local ecosystem while developing the system
support received. The system will also contribute to the easy identification of diseases with similar symptoms. It will be able to detect all kinds of diseases with a single sample, determined by the device developed and designed according to the needs of the hospital. Thus, much faster diagnosis and treatment will be provided with cost effective solutions.
Ethics committee approval process ongoing prototype system, the next step in Turkey Pharmaceuticals and Medical Devices
It will be submitted for approval in the institution (TITCK). After the hospital clinical tests are completed, the mass production phase will begin.
Can be used for different diseases
The sample taken from the patient will be ready for analysis in about 2 hours. Studies are continuing to shorten this period and the analysis result can be obtained in the order of minutes.
The developed device can be used for different scenarios without changing the main unit. In the system, there is the possibility to develop cassettes according to the needs of all kinds of diseases. Therefore, it will be able to take care of pathogens that cause upper respiratory tract infection when needed. If necessary, it will be able to use it for different system diseases. Thus, our hospitals will be able to use them in a wide variety of areas.